Integra LifeSciences Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Integra LifeSciences Holdings şirketinin kazançları yıllık ortalama -1% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 12% oranında artan oldu. Gelirler yıllık ortalama 1.8% oranında artan oldu.
Anahtar bilgiler
-1.0%
Kazanç büyüme oranı
-0.2%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 8.9% |
| Gelir büyüme oranı | 1.8% |
| Özkaynak getirisi | -0.4% |
| Net Marj | -0.4% |
| Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Integra LifeSciences Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 24 | 1,565 | -7 | 634 | 91 |
| 30 Jun 24 | 1,567 | 24 | 619 | 87 |
| 31 Mar 24 | 1,530 | 40 | 595 | 81 |
| 31 Dec 23 | 1,542 | 68 | 593 | 83 |
| 30 Sep 23 | 1,543 | 101 | 595 | 84 |
| 30 Jun 23 | 1,545 | 131 | 601 | 81 |
| 31 Mar 23 | 1,562 | 172 | 615 | 84 |
| 31 Dec 22 | 1,558 | 181 | 614 | 82 |
| 30 Sep 22 | 1,565 | 173 | 625 | 81 |
| 30 Jun 22 | 1,567 | 166 | 619 | 82 |
| 31 Mar 22 | 1,559 | 157 | 614 | 79 |
| 31 Dec 21 | 1,542 | 169 | 637 | 93 |
| 30 Sep 21 | 1,526 | 216 | 604 | 74 |
| 30 Jun 21 | 1,509 | 206 | 597 | 72 |
| 31 Mar 21 | 1,378 | 170 | 555 | 68 |
| 31 Dec 20 | 1,372 | 134 | 595 | 77 |
| 30 Sep 20 | 1,378 | 56 | 573 | 77 |
| 30 Jun 20 | 1,387 | -3 | 584 | 78 |
| 31 Mar 20 | 1,512 | 27 | 623 | 81 |
| 31 Dec 19 | 1,518 | 50 | 688 | 80 |
| 30 Sep 19 | 1,506 | 60 | 608 | 74 |
| 30 Jun 19 | 1,493 | 101 | 610 | 75 |
| 31 Mar 19 | 1,475 | 83 | 608 | 76 |
| 31 Dec 18 | 1,472 | 61 | 691 | 78 |
| 30 Sep 18 | 1,458 | 80 | 607 | 75 |
| 30 Jun 18 | 1,371 | 70 | 572 | 70 |
| 31 Mar 18 | 1,287 | 69 | 546 | 66 |
| 31 Dec 17 | 1,188 | 65 | 517 | 63 |
| 30 Sep 17 | 1,075 | 49 | 475 | 60 |
| 30 Jun 17 | 1,047 | 66 | 460 | 60 |
| 31 Mar 17 | 1,014 | 68 | 446 | 59 |
| 31 Dec 16 | 992 | 75 | 431 | 58 |
| 30 Sep 16 | 985 | 61 | 426 | 57 |
| 30 Jun 16 | 958 | 9 | 415 | 56 |
| 31 Mar 16 | 919 | 9 | 395 | 53 |
| 31 Dec 15 | 883 | 7 | 377 | 50 |
| 30 Sep 15 | 854 | 12 | 360 | 47 |
| 30 Jun 15 | 827 | 53 | 346 | 44 |
| 31 Mar 15 | 782 | 46 | 325 | 42 |
| 31 Dec 14 | 797 | 36 | 335 | 43 |
| 30 Sep 14 | 798 | 30 | 345 | 47 |
| 30 Jun 14 | 814 | -10 | 356 | 49 |
| 31 Mar 14 | 855 | -13 | 380 | 51 |
| 31 Dec 13 | 697 | 22 | 305 | 42 |
Kaliteli Kazançlar: IART şu anda kârlı değil.
Büyüyen Kar Marjı: IART şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: IART kârlı değildir ve zararlar son 5 yılda yılda 1% oranında artmıştır.
Büyüme Hızlandırma: IART 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil
Kazançlar vs. Sektör: IART kârlı olmadığından, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 10.4% ) karşılaştırılması zorlaşıyor.
Özkaynak Getirisi
Yüksek ROE: IART hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -0.43% ) sahiptir.